Medicenna Therapeutics Corp. - COM (MDNAF)

CUSIP: 58490H107

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COM
Total 13F shares
2,304,565
Share change
+441,978
Total reported value
$10,774,123
Price per share
$4.68
Number of holders
20
Value change
+$2,115,400
Number of buys
12
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 58490H107?
CUSIP 58490H107 identifies MDNAF - Medicenna Therapeutics Corp. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Medicenna Therapeutics Corp. - COM (MDNAF) as of Q4 2020

As of 31 Dec 2020, Medicenna Therapeutics Corp. - COM (MDNAF) was held by 20 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,304,565 shares. The largest 10 holders included AWM Investment Company, Inc., Verition Fund Management LLC, Soleus Capital Management, L.P., RENAISSANCE TECHNOLOGIES LLC, SILVERARC CAPITAL MANAGEMENT, LLC, TOCQUEVILLE ASSET MANAGEMENT L.P., DEUTSCHE BANK AG\, Rathbone Brothers plc, Creative Planning, and McKinley Carter Wealth Services, Inc.. This page lists 20 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.